from InterStudy (now called the Health Outcomes Institute) in America, on which the anglicised versions used in the Sheffield study and the Oxford healthy life study were based, and two more recent versions Objective-To assess the validity, reliability, and acceptability of the short form 36 (SF36) health survey questionnaire (a shortened version of a battery of 149 health status questions) as a measure of patient outcome in a broad sample of patients suffering from four common clinical conditions. Design-Postal questionnaire, foliowed up by two reminders at two week intervals.
Introduction
The govemment has responded to the need for efficient provision of health care by introducing managed competition into the National Health Service.' In the internal market health authorities and fundholding practices may purchase care from competing provider units. If the reforms are to be successful, then purchasers will require valid, reliable, and sensitive measures of outcome to allow them to allocate scarce resources in the most cost effective manner. Similarly, service providers who can demonstrate the effectiveness of the care they provide in improving patient outcome will be better placed to compete for purchaser funds. Without such information health care will be purchased on the basis of cost alone, with serious consequences for its quality.
Few outcome measures currently available for routine use satisfy the criteria of validity, reliability, and sensitivity to changes in health status. For example, the Nottingham health profile has been criticised for failing to detect low levels of morbidity.2 A measure that deserves careful consideration is the short form 36 (SF 36) health survey questionnaire.34 The SF36 is a shortened version of a battery of 149 health status questions developed and tested on a population of over 22 000 patients as part of the medical outcome study,5 6 designed to help understand how specific components of the American health care system affect the outcomes of care. A key objective of the study was to develop more practical tools for monitoring patient outcomes in a busy clinical setting. Questions were selected to produce a questionnaire that could be completed in under 10 minutes while retaining the validity and reliability of the longer parent questionnaire.
The SF 36 is a general outcome measure. In contrast with condition specific measures, which may be criticised for their narrowness, general measures attempt to capture aspects of health that are important to all patients. They are useful for health status comparisons both among patients with the same condition and between patients with different conditions. Such measures can also be administered to general populations to see how a particular condition causes health to depart from a "healthy standard."78 The SF 36 uses eight health scales to measure three aspects of healthfunctional status, wellbeing, and "overall evaluation of health" (see table I ). The responses to the questions on each scale are summed to provide eight scores between O and 100. 
Subjects and methods
Between March and June 1991 we identified patients in Grampian presenting with one of four common conditions-low back pain, menorrhagia, suspected peptic ulcer, or varicose veins. These patients were identified in one of two ways-from all referral letters to outpatient departments in Grampian, and by general practitioners from four large training practices in Grampian; this second group of patients was included only if the general practitioner did not refer them to a specialist during the recruitment period. General practitioners were also asked to assess their patients on a four point scale of symptom severity (none, mild, moderate, severe).
A questionnaire including an anglicised version of the SF 3610a and sociodemographic questions was sent to the patients in general practice within two weeks of their initial consultation and to referred patients before their first outpatient appointment. Patients not wishing to take part in the study were asked to return their questionnaires blank. Reminders were sent to nonrespondents after two weeks and again after four weeks. A random sample of 900 members of the general population, selected from the electoral register for Aberdeen, served as a comparison group. They were sent a similar questionnaire.
To test for response bias, patients who did not respond or refused to take part in the study were compared with respondents in age, gender, clinical condition, source, and reported symptom severity. In addition, a sample ofnon-respondents were telephoned at home and asked questions about health and socioeconomic status. Detailed analysis of these interviews will be reported later.
STATISTICAL ANALYSIS An outcome measure should be both reliable and valid. Validity is the extent to which an instrument measures what is intended." Reliability is the extent to which similar measurements on the same person are similar in different settings." In this paper we assess reliability through intemal consistency, which measures the extent to which similar questions produce consistent responses."
INTERNAL CONSISTENCY
The SF36 would be intemally consistent if the responses to items (that is, questions) that contribute to the same scale correlate well with each other. Two techniques were used to assess the intemal consistency of the SF 36-item-scale correlations" and Cronbach's Ot.'2 Item-scale correlations, which assess the extent to which an item is related to the remainder of its scale, should exceed 0-4.1" Furthermore, items should be more closely related to their own scale than the other scales. Cronbach other patients across five of the scales. The exceptions were mental health and energy or fatigue, where patients with menorrhagia scored as low as back pain patients, and general health perception, where peptic ulcer patients scored as low. Patients with varicose veins consistently scored the highest, the only exception being with respect to physical functioning. Only four of the differences in mean scores between patients and the general population failed to reach statistical significance-those for physical functioning in patients with menorrhagia and suspected peptic ulcer, and those for social functioning and general health perception in patients with varicose veins. Figure 1 presents the standard scores for an average member of the general population and the same patient with each condition in tum. The mean for the general population is set at zero on each health scale, allowing comparisons to be made in terms of standard deviations of the general population. For example, low back pain patients with a mean standard score of about -2 for pain corresponded to the lowest scoring 2 5% of the general population. Each condition had a distinctive profile. Patients with varicose veins scored highest on seven of the eight health scales and had a health profile that was closest to that of the general population, followed by patients with suspected peptic ulcer, menorrhagia, and low back pain.
Referred patients consistently had lower average scores on all eight scales than non-referred patients with the same condition ( table III, fig 2) . The only exception was menorrhagia, where the physical functioning scores of both referred and non-referred patients were not significantly different from those of the general population.
Finally, table III shows that for all eight health scales mean scores were ordered strictly according to general practitioners' perceptions of symptom severity. This linear relation was significant at the 1% level for all eight scales.
Discussion
To achieve its goals of efficiency and quality of care the new NHS needs an information system that will allow purchasers and providers to "estimate as best they can the relation between medical interventions and health outcomes."2' Such a system will require measures of outcome that are valid, reliable, and acceptable to patients. Our surveys have shown that the SF 36 health profile, developed and validated in the United States,"-7 is acceptable to patients in general practice and outpatient clinics, with a response rate around 75%. Our findings also confirm that its psychometric validity and reliability have remained intact. For example, factor analysis confirms the relevance of the eight health scales proposed by the original authors.
Clinical validity was shown by clear differences in self reported health between the general population and patients with four common conditions. Highly significant differences were found even for varicose veins, often perceived as a minor condition. Further evidence of validity was provided by the differences that the SF 36 detected between referred and nonreferred patients across all four conditions and all eight health scales, and by a high level of agreement between SF 36 scores and general practitioners' perceptions of symptom severity.
Together these last two findings suggest that, despite wide variations in referral patterns,22 general practitioners base referral decisions, certainly in part, on the severity of patients' conditions. To what extent this severity is related to patients' capacity to benefit from specialist treatment we shall not know until we have analysed surveys that followed up our 1300 patients 12 months after their original referral or consultation. These surveys will also enable us to test the sensitivity of the SF36 to changes in patients' health.
Finally, we emphasise that the SF 36 health profile is recommended not as a self contained questionnaire but as part of a more comprehensive portfolio of measures to assess many aspects of patient outcome. Such a portfolio should also include a condition specific measure of clinical outcome. As well as providing information that is more relevant to clinical decisions, such a measure might be more sensitive to changes in health after specialist treatment. The contribution of the SF 36 to such a portfolio of measures and its relation to clinically derived condition specific questionnaires20 need further study. We hope that our follow up will contribute to the growing programme of British research into the SF 36 health profile.
Introduction
Numerous epidemiological studies have shown an association between smoking and cervical cancer. ' The evidence for this association is based on population and case-control studies. Many of the studies in which other known risk factors for cervical cancer are adjusted for have shown that women who smoke have up to four times higher risk of developing cervical cancer than non-smokers.2 These epidemiological studies, however, do not provide the essential molecular evidence to show whether this relation between smoking and cervical cancer is casual or causal. In 1986 the International Agency for Research on Cancer (IARC) reviewed the available epidemiological data and concluded that there was insufficient evidence at that time to include smoking as a causal agent of cervical cancer. 3 Many chemical carcinogens exert their biological activity through covalent modification of DNA to form adducts. In the human respiratory tract, where the association between smoking and cancer is unequivocal,3 it has been clearly shown that DNA from smokers has significantly higher proportions of adducts than that of non-smokers.'7 Also cotinine, a metabolite of nicotine, has been detected in the cervical mucus of women, showing that the cervical epithelium is exposed to components of tobacco smoke.8 9 We investigated the presence of DNA adducts in normal squamous cervical epithelium by using postlabelling with phosphorus-32 and compared the results with the smoking habits of the women.
Subjects and methods
Women requiring a hysterectomy for benign disease or colposcopy after abnormal results of a cervical smear test were recruited into the study. They were interviewed on admission and asked to complete a questionnaire which asked whether they had ever (currently or previously) smoked. If so, then the length of time they had smoked, the number of cigarettes they smoked a day, and last time they smoked were recorded. Women who reported that they had never smoked were recorded as such. All women were asked whether they had smoked in the preceding 48 hours. Questions on passive exposure to tobacco carcinogens and general health were included. Approval from an ethical committee and informed consent were gained for participation in the study.
A urine specimen was collected at the time of interview to assay for cotinine. The pH was recorded and the sample frozen at -20°C until analysis. Urine samples were also collected from 19 medical staff (known non-smokers) to act as controls.
A punch biopsy specimen of normal ectocervical epithelium (acetowhite. negative areas) was obtained from each woman undergoing colposcopy. A biopsy specimen of ectocervical epithelial tissue (about 6 mm x 10 mm) was excised from the anterior lip of the cervices of women who had a hysterectomy. The samples were frozen immediately and stored at -20°C until analysis.
DNA extraction-DNA was isolated from thawed biopsy specimens essentially as described previously."
The DNA yield from each sample was determined spectrophotometrically. 32P posdabelling-Samples of 4 ,ug of DNA were
